Considerations governing factor IX product choice in hemophilia B.
G L
GL
Bray
L M
LM
Aledort
D004340:Drug Contamination / Q000517:prevention & control; D005164:Factor IX / Q000627:therapeutic use*; D002836:Hemophilia B / Q000188:drug therapy*; D006801:Humans; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission
D005164:Factor IX